Analyst Price Targets — NEXI
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 16, 2022 8:04 am | — | Barclays | $2.00 | $1.19 | Benzinga | Barclays Maintains Overweight on NexImmune, Lowers Price Target to $2 |
| August 16, 2022 7:28 am | — | Raymond James | $3.00 | $1.26 | Benzinga | Raymond James Maintains Outperform on NexImmune, Lowers Price Target to $3 |
| June 1, 2022 7:28 am | — | BTIG | $5.00 | $2.28 | Benzinga | BTIG Initiates Coverage On NexImmune with Buy Rating, Announces Price Target of $5 |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
No recent news available for NEXI.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NEXI.
U.S. House Trading
No House trades found for NEXI.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
